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Process Description
The basis for this evidence based project was found on a Transitional Care Unit. The unit had yet
to update their TB risk-assessment and treatment policy in response to the new guidelines set by the
Kentucky Department for Public Health in April of 2016. This policy falls under the infection control
program, but each unit director is tasked with updating the policy in specificity to their unit, basing their
changes on the skillsets and tendencies of their staff. The Director of the TCU identified this as one of
the primary concerns in regards to infection control on the unit, as the policy was not only outdated but
was also failing to be correctly followed by most, if not all of the staff.
The largest current problem is the old policy being outdated in terms of following the most
recent evidence based research. The new Kentucky Department of Health Guidelines in relation to TB
testing and treatment find their basis in studies done by the World Health Organization and the Centers
for Disease Control and Prevention. In particular, the new guidelines set a different structure of
treatment based on the induration results of the Mantoux Skin Test and also establish a protocol for HIV
positive patients or those suspected of being HIV positive. The former policy at The facility does not
provide detailed rules for HIV treatment in relation to a positive Tuberculosis Skin Test (TST). The lack of
specificity in this policy is concerning when compared to the detailed description of care and infection
control for HIV positive patients and those who could be positive for Tuberculosis.
There are numerous interventions that could be implemented to help reconcile this issue. The
most basic of interventions can be done from the administrative level in the form of employee
education. The largest concern for me when talking to the director was that most employees only
partially completed the TB Risk Assessment Form, which is up to date with Kentucky standards.
Completion of the assessment is crucial to the first step of finding a possible Mycobacterium
tuberculosis infection. Non-compliance in regards to completion of the entire assessment puts the unit,
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its employees, and its patients at risk. Employee education on the importance of assessment for TB and
Latent TB Infections could result in a more vigorous testing of patients admitted to the unit, and a better
quality control of infection.
A second intervention that could be useful in establishing a more rigorous infection control
program is education on the Kentucky guideline changes, and the associated changes to the old policy
on the unit. An education seminar or information posted throughout the unit could help employees to
understand not only the changes made to the policy but also the evidence behind the alterations to the
policy. Any education on the topic could help nurses become more understanding of the Risk
Assessment Form and more compliant in its completion.

Theoretical Framework
The theoretical framework that I chose to base my research on was one presented by Faye
Abdellah from her article “Better Patient Care Through Nursing Research”, which was published in the
International Journal of Nursing Studies. In the article she describes 21 nursing problems related to
patient care, with each one identifying an area of patient care that needs improvement. One of those
problem areas she states is “To promote safety through prevention of accidents, injury, or other trauma
and through the prevention of the spread of infection,” (Abdellah, 1965). She describes nursing as a
service to patients that should focus on disease control on a patient specific basis, rather than as a
blanket technique for all.
This framework suits the topic of TB Policy and Risk Assessment best due to the patient specific
nature of the Risk Assessment Form. The Risk Assessment is done on each patient, and although some
may have similar answers we are still able to identify those who need treatment based on the Risk
Assessment Identifiers that they’ve been linked to. In this way, a detailed Risk Assessment Form and
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Policy will help the unit to hone in on the patient and their needs, rather than blanketing everyone in
hopes of preventing the spread of TB infections.

Evidence
The research method was careful reading of the old and new policy, as well as the Kentucky
guidelines for the new policy. The research from the WHO that the Kentucky Department for Public
Health based their guidelines on was available. The article is a Level 1 meta-analysis from the World
Health Organization that combined the research from numerous studies done by their TB Impact Task
Force, which works each year to research and identify better ways of identifying and treating TB. Their
meta-analysis on the impact of TB in a world scope and its implications on world health identified TB
screening and prevention as a top priority to aid in reducing the number of active TB cases each year.
They have set goals for 2050 to “reverse the number of TB cases per year” as well as honing current
treatment and isolation practices (World Health Organization, 2009).
A second useful research article was completed in 2011 in South Africa by researchers from
multiple countries. The study focused on the effectiveness of a Tuberculin Skin Test in contrast to the
more recent testing using QuantiFERON Gold, a blood assay test. This study was performed in South
Africa in the town of Worcester, which has a TB prevalence of 1400 per 100,000 individuals. The
experiment was completed by enrolling adolescents between the ages of 12-18 years old, drawing blood
from each individual to be used for the interferon blood assay test, then immediately administering a
Mantoux test, which was read 48-96 hours later. Results show that the TST was equally as effective in
diagnosing possible TB skin test infections as the blood assay tests with a 96% confidence rate. The
article mentions that although the blood assays test may be more effective at discovering latent TB
infections and do not require a follow up visit, the cost-benefit analysis shows that the extra resources
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spent on laboratory testing materials for the blood assays does not increase screening effectiveness
adequately to justify the expense (Mahomed et al., 2011).
Among other research completed, a final noteworthy piece was one completed by a group of
European practitioners and infection researchers studying current approaches to tuberculosis case
detection and improving upon them. The study focused on a local approach to individualizing
assessment and evaluation of case detection methods, rather than a blanket approach proposed by
multinational healthcare corporations. It focused on high risk patients living in different socioeconomic
conditions in different locations in the world and attempted to find a way to individualize case detection
by using local healthcare professionals’ expertise on the area in order to customize assessment
accordingly. The group found that “Identifying key populations with high numbers of undiagnosed TB
and understanding health-seeking behavior and the barriers to TB detection are necessary first steps
when developing an intervention and an approach to measure its effectiveness,” (Blok et al., 2014).
Study results showed that Risk Assessments tailored to the patient population and recognizing barriers
to detection in unique areas helped to increase case detection and subsequent interventions for
treatment.

Proposed Policy
The following is an updated version of the old policy on the Transitional Care Unit. The changes
are almost entirely based on the sample unit policy presented by the Kentucky Department of Public
Health, which is in turn based on recommendations from the WHO and CDC. The text from the old policy
is written in black, with the new changes shown in red text. The bulk of the policy change is contained in
two sections, so only those sections are included. The updates are written in the format used by the
facility.
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TCU shall not admit a person under medical treatment for suspected or confirmed pulmonary or extrapulmonary tuberculosis disease cause by mycobacterium tuberculosis or any other infectious form of
tuberculosis regardless of drug-resistant status unless declared noninfectious by a physician, APRN, or
physician assistant in collaboration with the local and state health departments. Documentation of
infectious status shall be included upon admission or transfer.
1. A TB Risk Assessment shall be completed in full on each patient admitted to TCU. To
perform a risk assessment the following factors will be assessed:
a. The clinical symptoms of active TB disease
b. Events and behaviors that increase the risk of exposure to mycobacterium
tuberculosis and the risk of requiring latent TB infection (LTBI).
c. Medical risk factors that increase the risk for a patient with LTBI to develop
active TB disease
Risk assessment results will be documented in the patient’s medical record.
2. TB skin testing of all residents on admission using the Mantoux technique (5 units of PPD
intradermally) will be completed before or during the first week of admission unless the
resident has provided medical documentation for one of the following as part of a TB risk
assessment.
a. Previous documented skin test of 10mm induration if interpreted as positive
b. A prior TST of 5mm to 9mm of induration interpreted as positive if the patient has a
medical reason described below:
i. HIV infection (Farmer et al., 2011)
ii. Immunosuppression from disease or medications
iii. Fibrotic changes on a chest radiograph consistent with TB
iv. Recent contact with someone diagnosed with active TB
c. Is currently receiving or has completed 6 months of prophylactic therapy or a course of
multiple-drug chemotherapy for TB as recommended by the Centers for Disease Control
and Prevention.
d. Can supply documentation of a TB skin test within 3 months prior to admission.
e. A positive BAMT (Blood Assay for Mycobacterium Tuberculosis).
f. A TST or BMT conversion.
3. For residents whose initial first step skin test is interpreted as negative, the two step skin
test is required (a second skin test is given within 7-14 days of the first) unless they can
document that they have had a negative TB skin test within 1 year of admission.
4. A BAMT may be used in place of, but not in addition to the 2 step TB testing. If a BAMT is
performed before or during the first week of admission and the result is determined only
one BAMT test result shall be required. A second BAMT shall be performed if the result of
the initial BAMT is borderline, indeterminate, or invalid.
5. Residents found on admission to have a skin test of 10mm or more of induration may be
interpreted as positive.
6. Residents found on admission to have a skin test of 5mm to 9mm of induration may
interpreted as positive for the following medical reasons:
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7.
8.

9.

10.

11.

12.

a. HIV infection
b. Immunosuppression from disease or medication
c. Changes on a chest radiograph consistent with TB disease
d. Recent contact with someone diagnosed with active TB.
The TST result of each patient will be documented in the medical record, recording date,
millimeters of induration, and interpretation of results.
Residents with a positive TST, BAMT, TST conversion, or BAMT conversion shall receive a
chest x-ray unless a chest x-ray done within 2 months prior shows no evidence of TB or
documentation of completion of a course of prophylactic treatment for TB. A medical
evaluation will be performed and include HIV testing unless the patient or responsible party
opts out of HIV testing.
A patient with a positive TST, BAMT, TST conversion, or BAMT conversion but has no clinical
evidence of active TB upon evaluation by a licensed physician, APRN, or PA and has a
negative chest x-ray will be offered treatment for LTBI.
Residents with positive skin tests (10mm or more, 5-9mm in patients with medical reasons
indicated above) or positive BAMT result will be reported to the Infection Control
Practitioner (ICP) who will in turn notify the local public health department coordinator and
be monitored for signs and symptoms of infection.
All residents will be monitored for signs and symptoms of infection. The ICP, Employee
Health, or designated relief nurse should be consulted for any potential or actual infections
which place the resident, other residents, visitors, family, or employees at risk.
A long-term care setting’s administrator or their designee shall report a resident identified
with one of the following to the local health department having jurisdiction within one
business day upon identification:
a. A TST or BAMT conversion upon testing or identified in a contact investigation.
b. A chest x-ray suspicious for TB disease.
c. A sputum smear positive for acid-fast bacilli.
d. A rapid lab test positive for Mycobacterium tuberculosis DNA or RNA.
e. Sputum cultures positive for mycobacterium tuberculosis.
f. The initiation of multi-drug tuberculosis treatment for a resident.

Implementation into Professional Practice
The implementation of this policy should focus on employee education in regards to the
research behind the new guidelines, rather than simply outlining the changes to the policy. If the
employees understand why the changes have been made and how that affects patient care, outcomes,
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and infection control, then they are more likely to adhere to the new policy long-term. Outlining the
changes and spending no time educating employees about the evidence based research behind the
changes will likely cause a short-term compliance with the new policy.
The best way to educate the staff can be split into two steps. The first step requires an
education in-service presentation to the employees of the unit in person. The most convenient way to
do this would be to record a video of the in-service and send it to employees, but the question of
compliance to watching the video remains. Therefore, the most effective education method would be to
present the in-service in person one time each day during both the day and night shift for the duration
of a week. This method would allow the material to be presented to everyone on the staff once, and
some will receive it multiple times. The second step is to create high-visibility posters or flyers to be
placed on the unit by the director in areas that are frequently visited by unit staff. Providing these flyers
provides constant education on the topic that is easy to access and is readily available.
Assessment of compliance will be a multidisciplinary task. While the director should certainly
observe the employees of the unit to assess compliance, this is not enough. By providing education on
the impact of the research and the necessity of the new policy, the unit can become accountable for
itself. If the employees successfully recognize the importance of the topic, they will hold each other
accountable through observation. Should employees fail to comply with the new policy the director will
determine how they should be reprimanded. Long-term compliance will be achieved once employees
recognize the impact of the Risk Assessment and TB screening that is outlined in the research studies.

Conclusion
In conclusion, the updated policy should reflect all of the guidelines set forth by the Kentucky
Department of Public Health, which in turn reflects the global goals of the World Health Organization
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and the Centers for Disease Control and Prevention. Adherence to this policy will be key in accurately
identifying patients who are at risk for developing TB or LTBI, especially those who may be HIV positive.
The Risk Assessment Tool will be crucial in the detection of new cases and prevention of the spread of
infection. The Transitional Care Unit at this facility will greatly benefit from the updated policy, and will
continue their excellence in infection control and prevention.
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